Activities, Bill Numbers and Titles
|
|
Client: Eli Lilly and Company
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $30,000.00
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
10/24/2023 |
Friends of John Lawn
|
State Representative
|
$200.00
|
| | Total contributions |
$200.00
|
|